EFFECTS OF AN N-METHYL-D-ASPARTATE ANTAGONIST AND A GABAERGIC ANTAGONIST ON ENTORHINAL TETANIC RESPONSES DURING THE EARLY STAGES OF AMYGDALA KINDLING IN RATS

被引:9
|
作者
HIRAYAMA, K [1 ]
MURATA, R [1 ]
MATSUURA, S [1 ]
机构
[1] OSAKA CITY UNIV,SCH MED,DEPT PEDIAT,ABENO KU,OSAKA 545,JAPAN
关键词
KINDLING; AMYGDALA; ENTORHINAL CORTEX; TETANIC RESPONSE; FACILITATION; NMDA ANTAGONIST; GABA ANTAGONIST; INHIBITION;
D O I
10.1016/0168-0102(94)90081-7
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Changes in synaptic potentials during each train stimulation (tetanic responses) have been suggested to intimately relate to the development of kindling. We examined the effects of an NMDA antagonist, carboxypiperazinephosphonate (CPP), and a GABAergic antagonist, picrotoxin, on entorhinal tetanic responses evoked by train stimuli (10 Hz, 100 pulses) at the developmental stage (seizure stage; 0-2) of amygdala kindling in conscious rats, to clarify the significance of facilitation in tetanic responses and the roles of NMDA and GABA receptors in the development of kindling. Facilitation of tetanic responses was noted as a progressive increase in both amplitude and duration of negative potentials in the tetanic responses, especially during the later half of train pulses (51-100). The negative potential area (mV x ms) of the averaged tetanic responses was used as an estimate of the magnitudes of excitatory synaptic activity in the tetanic responses, and correlated significantly (P < 0.001) with the duration of afterdischarges (AD). CPP (10 mg/kg) reversibly blocked AD in association with a significant decrease (P < 0.05) in the negative potential area. The CPP-sensitive component consisted of a slow negative potential with a duration longer than 60 ms and was greater in the later tetanic responses (51-100) than the earlier ones (1-50). Picrotoxin (2-3 mg/kg), which did not produce convulsions, significantly (P < 0.005) increased the negative potential area in the tetanic responses in association with a reversible decrease in the AD threshold. Although positive potentials ascribable to inhibitory synaptic activity were often negligible in the tetanic responses in controls, picrotoxin further decreased the positive potentials of tetanic responses, if any. We suggest from these results that facilitation of entorhinal tetanic responses during amygdala kindling stimulation is enhanced by NMDA-receptor activation and reduction of GABAergic inhibition, and that both NMDA and GABA receptors are responsible for the electrophysiological origin of the development of kindling.
引用
收藏
页码:397 / 405
页数:9
相关论文
共 50 条
  • [41] N-Methyl-D-Aspartate Receptor Antagonist Effects on Prefrontal Cortical Connectivity Better Model Early Than Chronic Schizophrenia
    Anticevic, Alan
    Corlett, Philip R.
    Cole, Michael W.
    Savic, Aleksandar
    Gancsos, Mark
    Tang, Yanqing
    Repovs, Grega
    Murray, John D.
    Driesen, Naomi R.
    Morgan, Peter T.
    Xu, Ke
    Wang, Fei
    Krystal, John H.
    BIOLOGICAL PSYCHIATRY, 2015, 77 (06) : 569 - 580
  • [42] Apoptosis following spinal cord injury in rats and preventative effect of N-methyl-D-aspartate receptor antagonist
    Wada, S
    Yone, K
    Ishidou, Y
    Nagamine, T
    Nakahara, S
    Niiyama, T
    Sakou, T
    JOURNAL OF NEUROSURGERY, 1999, 91 (01) : 98 - 104
  • [43] HYPOGLYCEMIA-INDUCED NEURONAL DAMAGE PREVENTED BY AN N-METHYL-D-ASPARTATE ANTAGONIST
    WIELOCH, T
    SCIENCE, 1985, 230 (4726) : 681 - 683
  • [44] Amantadine, an N-Methyl-D-Aspartate antagonist, for treatment of chronic neuropathic pain in a dog
    Madden, Megan
    Gurney, Matthew
    Bright, Steve
    VETERINARY ANAESTHESIA AND ANALGESIA, 2014, 41 (04) : 440 - 441
  • [45] The N-methyl-D-aspartate antagonist memantine retards progression of Huntington's disease
    Beister, A
    Kraus, P
    Kuhn, W
    Dose, M
    Weindl, A
    Gerlach, M
    JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT, 2004, (68): : 117 - 122
  • [46] APH, an N-methyl-D-aspartate receptor antagonist, blocks the metaphit-induced audiogenic seizures in rats
    Zivanovic, D
    Susic, V
    Stanojlovic, O
    JOURNAL OF PHYSIOLOGY-PARIS, 1997, 91 (06) : 317 - 323
  • [47] INTRAVENTRICULAR-INJECTION OF AN N-METHYL-D-ASPARTATE ANTAGONIST DISRUPTS VESTIBULAR COMPENSATION
    SANSOM, AJ
    DARLINGTON, CL
    SMITH, PF
    NEUROPHARMACOLOGY, 1990, 29 (01) : 83 - 84
  • [48] N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST DESEGREGATES EYE-SPECIFIC STRIPES
    CLINE, HT
    DEBSKI, EA
    CONSTANTINEPATON, M
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (12) : 4342 - 4345
  • [49] N-methyl-D-aspartate antagonist activity of alpha- and beta-sulfallorphans
    Shukla, VK
    Lemaire, S
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1997, 280 (01): : 357 - 365
  • [50] SUPPRESSION OF SPREADING DEPRESSION OF LEAO IN NEOCORTEX BY AN N-METHYL-D-ASPARTATE RECEPTOR ANTAGONIST
    MCLACHLAN, RS
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1992, 19 (04) : 487 - 491